Fibroblast growth factor 23 (FGF-23), a novel inducer of cardiac hypertrophy and fibrosis through pro-fibrotic gene transcription, is speculated to participate in cardiac remodeling with possible reversibility [5,6]. This evidence concerns the gene FGF23 and cardiac hypertrophy.